Patient ID
β2-AR 46A>G Gly16Arg β2-AR 79C>G Gln27Glu
β1-AR c.1165G>C p.Gly389Arg
β1-AR c.145A>G p.Ser49Gly
GNAS c.393C>T p.(Ile131=)
1 A/A C/C C/C A/A C/C
2 A/A C/C C/C A/A T/T
3 A/A C/C C/C A/G T/T
4 A/A C/C G/C A/A T/T
5 A/A C/C G/C A/A T/T
6 A/A C/C G/C A/G C/T
7 A/G C/C C/C A/G T/T
8 A/G C/C G/C A/G T/T
9 A/G C/C G/G A/A C/T
10 A/G C/G C/C A/A C/T
11 A/G C/G C/C A/A C/T
12 A/G C/G C/C A/A C/T
13 A/G C/G C/C A/A T/T
14 A/G C/G C/C A/G C/C
15 A/G C/G C/C A/G C/T
16 A/G C/G C/C A/G T/T
17 A/G C/G G/C A/A C/C
18 G/G C/G G/C A/A C/T
19 G/G G/G C/C A/A C/C
20 G/G G/G C/C A/A C/T
21 G/G G/G C/C A/A C/T
22 G/G G/G C/C A/G C/C
23 G/G G/G C/C A/G C/T
24 G/G G/G C/C A/G C/T
25 G/G G/G G/C A/A C/T
26 G/G G/G G/C A/A C/T
Allele incidence in the study population G – 55.8% C – 51.9% C – 80.8%, A – 80.8% T – 55.8%
Allele incidence in the Estonian population 19 G – 63% C – 58% C – 76% A – 84.5% T – 44.5%